Colon Cancer: Should Young People Worry?

What It Covers

Science Vs examines the rise of colorectal cancer in adults under 55, exploring why millennials face two to three times higher risk than boomers at the same age, why diagnoses arrive at later stages, and what new genetic research reveals about bacterial exposure in infancy as a potential root cause.

Key Questions Answered

• •Symptom recognition: Seek medical evaluation if bowel changes persist for weeks, not days. Specific warning signs include pencil-thin stools (indicating tumor pressure narrowing the colon), dark or bloody stool, and persistent abdominal pain. Vague symptoms like back pain can also signal advanced colorectal cancer, so sustained unexplained changes warrant a colonoscopy referral.
• •Screening age threshold: The recommended age for a first colonoscopy was lowered from 50 to 45 in the US, and some physicians advocate pushing it even lower. Colonoscopies catch precancerous polyps before they progress. Declining rates of colorectal cancer in older adults are attributed largely to consistent colonoscopy screening programs that detect and remove polyps early.
• •Diagnosis delay risk: Four in ten young colorectal cancer patients are initially told they are too young to have the disease, and young patients wait 40% longer than older patients to reach an oncologist. This delay allows tumors to advance; over half of early-onset cases are caught at stage three or four, when five-year mortality reaches roughly 80%.
• •Colibactin mutation pathway: Genetic analysis of nearly 1,000 colorectal tumors across 11 countries found that over 50% of patients under 40 carried a specific mutational fingerprint linked to colibactin, a DNA-damaging toxin produced by certain gut bacteria including some E. coli strains. Mouse studies confirm colibactin-producing bacteria increase tumor rates, supporting a causal link.
• •Early-life exposure window: Genomic tree analysis of tumor mutations estimates that colibactin-related DNA damage occurs before age 10, with more recent unpublished data narrowing the window to the first two years of life. Factors shaping infant microbiome development — antibiotic exposure, C-section delivery, and breastfeeding versus formula — are under investigation as potential contributors to elevated cancer risk decades later.